Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody
Background. Donor-specific antibodies (DSA) to human leukocyte antigen increase the risk of accelerated rejection and allograft damage and reduce the likelihood of successful transplantation. Patients with full-thickness facial burns may benefit from facial allotransplantation. However, they are at...
Saved in:
Main Authors: | Bruce E. Gelb, J. Rodrigo Diaz-Siso, Natalie M. Plana, Adam Jacoby, William J. Rifkin, Kimberly S. Khouri, Daniel J. Ceradini, Eduardo D. Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2018/7691072 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better
by: Lan Zhu, et al.
Published: (2025-01-01) -
Molecular Profiling of Acute and Chronic Rejections of Renal Allografts
by: Hřibová Petra, et al.
Published: (2013-01-01) -
Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection
by: O. Franzese, et al.
Published: (2013-01-01) -
Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
by: So Yeong Jeong, et al.
Published: (2025-01-01) -
COVID-19 and renal allograft rejection: insight from controlled and non-controlled studies
by: Ahmed Daoud, et al.
Published: (2024-12-01)